Status:
RECRUITING
Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis Patients
Lead Sponsor:
Ain Shams University
Conditions:
Cystic Fibrosis (CF)
Eligibility:
All Genders
6+ years
Brief Summary
To implement a quality improvement plan aimed at achieving a 5% increase in the Forced expiratory volume in 1st second (FEV1) (% predicted value) in cystic fibrosis (CF) patients with impaired pulmona...
Detailed Description
This study will be conducted on 35 children diagnosed with cystic fibrosis, aged between 6 and 18 years. Patients will be selected during their follow-up visits to the Pediatric Chest Clinic at Ain Sh...
Eligibility Criteria
Inclusion
- Pediatric CF patients diagnosed based on the Consensus Guidelines from the Cystic Fibrosis Foundation, with a positive sweat chloride test (≥60 milliequivalent/L) and/or the presence of two CF disease-causing gene mutations.
- Age ≥6 years.
- Forced expiratory volume in 1 second (FEV₁) ≤80%.
Exclusion
- ●Patients are unable to perform spirometry.
Key Trial Info
Start Date :
October 7 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 12 2025
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT06915961
Start Date
October 7 2024
End Date
December 12 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams university
Cairo, Abbasia, Egypt, 00202